[Accreditation of the activity of molecular pathology according to ISO 15189: key steps to follow and the main potential pitfalls]

Ann Pathol. 2013 Feb;33(1):12-23. doi: 10.1016/j.annpat.2012.11.004. Epub 2013 Jan 30.
[Article in French]

Abstract

The quick emerging of the several targeted therapies and the concept of personnalized medicine underlie the necessity to develop and to well organize a molecular biology (or molecular pathology) unit of high quality, dedicated to clinical care, in order to look for tissular and cellular theragnosis biomarkers. This new and sudden area of activity for a clinical pathologist is strongly linked to the knowledge of a new medical speciality in health care institutions. Thus, the molecular pathology (or molecular biology made from cellular or tissular samples) can nicely be implemented in a clinical pathology laboratory. This new mission for a pathologist has to be done in respect with a great quality assurance which should allow obtaining in a short-term an ISO 15189 accreditation to keep going to perform this activity. The present work aims to describe the main steps to be set up in the order to get an ISO 15189 accreditation in molecular pathology. The different chapters of this norm will not be described in their exhaustivity, but in their large lines. Finally, we will describe the potential difficulties and pitfalls to be avoided before getting this accreditation.

Publication types

  • English Abstract

MeSH terms

  • Accreditation / standards*
  • France
  • Guidelines as Topic
  • Humans
  • Pathology, Molecular / standards*